Detalhe da pesquisa
1.
A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration.
J Med Chem
; 63(5): 2372-2390, 2020 03 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31790581
2.
Ligand chain length drives activation of lipid G protein-coupled receptors.
Sci Rep
; 7(1): 2020, 2017 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28515494
3.
Early endogenous activation of CB1 and CB2 receptors after spinal cord injury is a protective response involved in spontaneous recovery.
PLoS One
; 7(11): e49057, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23152849
4.
Structure-activity relationship of a new series of reversible dual monoacylglycerol lipase/fatty acid amide hydrolase inhibitors.
J Med Chem
; 55(2): 824-36, 2012 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-22185522